FDA Approves Orgovyx, Oral ADT for Advanced Prostate Cancer
News
The U.S. Food and Drug Administration (FDA) has approved Orgovyx (relugolix), an oral form of hormone therapy by Myovant Sciences, to treat adults with advanced prostate cancer. The approval, granted ... Read more